Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis - Wikidata - awgldk - TriplyDB

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26859516

about

Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations Novel citation-based search method for scientific literature: application to meta-analyses.High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study.Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.Cardiovascular risk factor management in patients with RA compared to matched non-RA patients Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study.Cardiovascular comorbidity in rheumatic diseases.Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.Prevention of Stroke in Rheumatoid Arthritis.Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.JAK inhibition in inflammatory bowel disease.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.Baricitinib for the treatment of rheumatoid arthritis.JAK inhibitors in dermatology: The promise of a new drug class.Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis.Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis.Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Two meals with different carbohydrate, fat and protein contents render equivalent postprandial plasma levels of calprotectin, cortisol, triglycerides and zonulin.Chemical JAK inhibitors for the treatment of rheumatoid arthritis.Next generation of small molecules in inflammatory bowel disease.Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment

P2860

Q26744334-00F56366-5FED-429C-A80E-399BDACFE304 Q26772850-FD2228AE-2214-4D86-96FB-A92E30A39155 Q26775111-386DB773-3A76-4546-A957-F6ECEC8EFC3A Q27694518-C5AF1F94-4672-4531-86C6-D1C56391A654 Q35805087-19FDAE99-9AB0-4B34-9544-AA724FE35CB5 Q36155818-ADD0B95E-66B2-41D4-AF33-E0D0E3392419 Q36640598-E8FD6570-143C-4622-B5DD-03CF2B16F430 Q36795979-A9EDB7C7-DFCE-4E8F-8FDA-A4BEA3186884 Q37405950-E19978B7-6922-4916-8DB6-85F1FBD0FF02 Q38568465-705127B5-1D93-47B9-BAD2-7D707988BE90 Q38604390-13A4336B-9C9D-49A5-AC6E-7694DC1EA215 Q38612651-DFCD4EA8-391A-4A6B-9D9E-D7A613273918 Q38737288-09EE17BC-572F-4012-9207-B5F5E2B486B0 Q38741861-3494A73A-0590-4C44-BA6E-7809B77BC48A Q38761142-111D6E0F-0F25-4D52-A00E-73006C4FE649 Q38837769-E7323382-52D7-42F8-AD2F-EE1ACF62E22C Q38840787-2F53F2AE-0F58-4ED5-BE5C-B5D9476DEC43 Q39111032-8EE89E9C-C600-4701-A4B3-5FD2F06F8E63 Q39215606-16C162D0-6A75-48C4-8622-D483F928BA4E Q42696887-1C3F8B97-B34B-4814-88B4-624590D4B33E Q46089585-0D99788F-A178-45A9-80C4-C9D3058264DC Q46172380-F60BCCB2-1584-4EB2-9EA4-BF408A6E1FA2 Q47338654-1DD06A9A-3B08-4C6A-9BF3-FF8948323B17 Q47439880-ECF25D47-BB6E-40DA-998B-BBF55D462C23 Q48003836-EA880025-F515-4E09-B7EB-125E3CC82CCC Q48227295-C36F2FD6-24F3-4B3F-9EE9-5E425D7A3806 Q48556502-0103C4C3-D9D3-40E6-ABF9-03BBFB3EFC82 Q51675582-1949E1EA-4421-492A-9D46-D31E4537688E Q54172510-382C8F78-70A1-45E3-82D5-DAE646069B13 Q55007993-CD72DCDF-E2E7-430F-924B-5124492783ED Q58567872-3374586C-F917-4801-8104-3BBB7BAAA999

P2860

Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26859516

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Lipid profile changes in patie ...... matic review and meta-analysis

@ast

Lipid profile changes in patie ...... matic review and meta-analysis

@en

Lipid profile changes in patie ...... matic review and meta-analysis

@nl

type

label

Lipid profile changes in patie ...... matic review and meta-analysis

@ast

Lipid profile changes in patie ...... matic review and meta-analysis

@en

Lipid profile changes in patie ...... matic review and meta-analysis

@nl

prefLabel

Lipid profile changes in patie ...... matic review and meta-analysis

@ast

Lipid profile changes in patie ...... matic review and meta-analysis

@en

Lipid profile changes in patie ...... matic review and meta-analysis

@nl

P1433

Q26859516-0625F4F9-8564-4056-9314-BE86C99CE470

P1476

Q26859516-C1E4F67C-1E5B-4FE7-9C34-A30D4049A55E

P2093

Q26859516-17D6E834-9061-40BF-A291-70EDC6C8EAE3

Q26859516-3CAE3BE7-1D58-4A2E-9D17-7E453B6B6008

Q26859516-7F80BD8A-2D22-4726-8390-E654442C00C4

Q26859516-C73E0943-624D-4D5A-9659-1752DEA3E367

P2860

Q26859516-0241A0C9-5EF7-4B7A-B5D2-08F1FB1A6C76

Q26859516-0397DA38-604F-4E3D-B245-9C059D709ACF

Q26859516-048532F3-15BC-485C-9D2C-39797E9CF112

Q26859516-16442360-2558-47EB-9F40-34AFB1BAB083

Q26859516-1B6CD1DF-85BF-4232-83F5-3C4A2D7EB4F6

Q26859516-23D1BFAD-6B7B-4E60-814C-31AF003B5957

Q26859516-28603851-9471-4524-9D31-339DB894B241

Q26859516-34CC702C-335B-4C9B-AC27-E7CCFDEFCFD2

Q26859516-358C3FB7-F63B-4C8C-820B-4FCC419874E0

Q26859516-448356C2-D5F8-485B-AA86-878910E14DC1

P304

Q26859516-FBEBEFCC-86CF-4ED0-BED6-8F63837C9F70

P31

Q26859516-39E67020-3D9A-4A9E-BEDF-1A65E64C2FF3

Q26859516-7FDD2944-B1EC-49D2-957A-E9EC877330C7

Q26859516-FDF2D315-484F-4166-BA5C-522DA7374063

P3181

Q26859516-49E88C66-CAD2-44F1-B4A6-273D1F9E8AFC

P356

Q26859516-B54B87FD-BF5F-417D-ACD3-18366C6003A3

P407

Q26859516-7EED7BEC-E517-45F1-B93F-9E4072EEF0C9

P433

Q26859516-88A295BC-BF3C-4B3F-B795-AC9F9167CBEE

P478

Q26859516-DC1B8470-B323-4D63-873C-9BD2F26159DF

P50

Q26859516-831641F0-A3CF-46C1-B30C-64590C48C1B7

Q26859516-D56E5B31-A8ED-4757-9920-8C318C7DD7E1

P577

Q26859516-5E83B19B-4538-44F9-B241-377E93A46B96

P5875

Q26859516-8A3751AB-BA64-40AF-B7A9-47BABE6F1C1B

P698

Q26859516-34D5C193-C0BB-403A-B696-966F9F0A80BA

P921

Q26859516-99012646-BAB8-496F-9C96-C9B575ED2CEE

Q26859516-C62ADF91-61BC-4593-B982-31717269F073

P3181

P356

P1433

Arthritis & Rheumatology

P1476

Lipid profile changes in patie ...... matic review and meta-analysis

@en

P2093

Alejandro Souto

http://www.w3.org/2001/XMLSchema#string

Antonio Mera

http://www.w3.org/2001/XMLSchema#string

Eva Salgado

http://www.w3.org/2001/XMLSchema#string

Juan J. Gómez-Reino

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

Total cholesterol and LDL levels decrease before rheumatoid arthritis.

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).

P304

117-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

2597100

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.38894

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

José Ramón Maneiro

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266679255

http://www.w3.org/2001/XMLSchema#string

P698

25303044

http://www.w3.org/2001/XMLSchema#string

P921